Craig F. Courtemanche Jr. - 10 Mar 2026 Form 4 Insider Report for PROCORE TECHNOLOGIES, INC. (PCOR)

Role
Director, Chairman of the Board
Signature
/s/ Benjamin C. Singer, Attorney-in-Fact
Issuer symbol
PCOR
Transactions as of
10 Mar 2026
Net transactions value
-$3,211,889
Form type
4
Filing time
12 Mar 2026, 21:20:18 UTC
Previous filing
24 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Courtemanche Craig F. Jr. Director, Chairman of the Board C/O PROCORE TECHNOLOGIES, INC., 6309 CARPINTERIA AVE, CARPINTERIA /s/ Benjamin C. Singer, Attorney-in-Fact 12 Mar 2026 0001805735

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCOR Common Stock Options Exercise +56,121 +6.1% $2.42* 983,701 10 Mar 2026 Direct
transaction PCOR Common Stock Sale $1,992,883 -34,969 -3.6% $56.99 948,732 10 Mar 2026 Direct F1, F2
transaction PCOR Common Stock Sale $1,143,481 -19,859 -2.1% $57.58 928,873 10 Mar 2026 Direct F1, F3
transaction PCOR Common Stock Sale $75,524 -1,293 -0.14% $58.41 927,580 10 Mar 2026 Direct F1
holding PCOR Common Stock 2,692,461 10 Mar 2026 See Footnote F4
holding PCOR Common Stock 1,155,480 10 Mar 2026 See Footnote F5
holding PCOR Common Stock 527,349 10 Mar 2026 See Footnote F6
holding PCOR Common Stock 23,736 10 Mar 2026 Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCOR Stock Option (Right to Buy) Options Exercise -56,121 -12% $2.42* 392,854 10 Mar 2026 Common Stock 56,121 $2.42 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares sold pursuant to a 10b5-1 plan dated December 9, 2025.
F2 The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $56.36 to $57.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $57.36 to $58.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 These shares are held by the Craig F. Courtemanche and Hillary Courtemanche Family Trust dated as of November 1, 2012.
F5 These shares are held by the Courtemanche 2021 Irrevocable Trust UA DTD 6/10/2021.
F6 These shares are held by The Courtemanche 2016 Irrevocable Trust.
F7 The shares subject to the option vested in 60 equal monthly installments beginning on the one month anniversary of February 5, 2016, subject to continued service through each applicable vesting date.